Actinomycin-Based Near-IR Nucleic Acid Stains for Rapid Cell Cycle Analysis

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current fluorescent dyes like 7-AAD require long incubation times for staining and exhibit high variability in DNA content cell cycle analysis, making them unsuitable for high-throughput applications and rapid analysis.

Innovation Solution

Development of actinomycin-based near IR emitting compounds that selectively and rapidly stain cells with compromised membranes, reducing incubation times and minimizing variability in DNA content cell cycle analysis.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If 7-AAD is used as a nuclear stain, then DNA affinity and fluorescence emission are achieved, but incubation time is prolonged

Engineering Contradiction:
ImproveDNA staining capabilityVSAvoidincubation time
Core Design Contradiction:
Measurement precisionVSLoss of time

Solution Approach 1:

The patent modifies the chemical structure of actinomycin D by replacing the phenolic hydroxyl group with various substituents (R1-R6 groups including aromatic rings, heterocycles, and alkyl chains), which changes the molecular parameters to achieve both rapid membrane permeation and strong DNA binding affinity, reducing incubation time from 30 minutes to 5 minutes or less

Inventive Principle:
Principle #35Parameter changes

2Measurement precision

If 7-AAD is used for DNA content cell cycle analysis, then DNA staining is achieved, but measurement variability increases

Engineering Contradiction:
ImproveDNA content measurementVSAvoidhistogram variability
Core Design Contradiction:
Measurement precisionVSReliability

Solution Approach 1:

The structural modifications to actinomycin D (changing R groups at positions 4a and 12a) alter the binding parameters and stoichiometry, resulting in more uniform DNA staining with reduced coefficient of variation in G0G1 peak measurements, thereby improving reliability of cell cycle analysis

Inventive Principle:
Principle #35Parameter changes

3Object-affected harmful factors

If fluorescent dyes with longer wavelength are used, then background interference is reduced, but detection sensitivity decreases

Engineering Contradiction:
Improvebackground fluorescence interferenceVSAvoiddetection sensitivity
Core Design Contradiction:
Object-affected harmful factorsVSMeasurement precision

Solution Approach 1:

The patent creates composite fluorescent structures by combining actinomycin D core with various aromatic and heterocyclic substituents, achieving a balance where the extended conjugation system provides near-infrared emission (reducing background interference) while maintaining strong absorption coefficients and fluorescence quantum yields for sensitive detection

Inventive Principle:
Principle #40Composite materials

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The actinomycin-based compounds enable rapid staining and analysis, providing low variability in DNA content cell cycle measurements and stability under intense illumination, making them suitable for high-throughput applications and multiplex assays.

Implementation Method 1

The actinomycin-based compounds of the invention selectively and rapidly associate with nucleic acid molecules... exhibit very long wavelength emission bands upon excitation with light of an appropriate wavelength

Methodology Applied
Scientific EffectFluorescence: Fluorescence

Implementation Method 2

Certain fluorescent compounds have a strong affinity for DNA and can serve as a fluorescent marker for DNA... 7-AAD can be efficiently excited using standard helium-neon and argon lasers

Methodology Applied
Scientific EffectIntercalation:

Data Source

PatentUS8653261B2Modified actinomycin-based nucleic acid stains and methods of their use
Publication Date: 2014.02.18 LIFE TECHNOLOGIES CORP
  • US8653261B2 patent drawing
  • US8653261B2 patent drawing
  • US8653261B2 patent drawing

AI summary

Actinomysin-based near IR emitting compounds and methods of their use as nucleic acid stains are provided. The actinomysin-based near IR emitting compounds have the structure:wherein R is H or NH2; R1, R2, R3, and R4 are independently a moiety comprising 1-30 atoms selected from H, O, C, and N, wherein the atoms are in a linear, branched, or cyclic configuration; R3 and/or R4 comprise a quaternary nitrogen atom; and R5 is H, F, or Cl.